Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Quantum Computing as a Foundational Framework for Advancing Cancer Research

Muhammad Vanalli

Published Jan 1, 2026• 0 citations
Publisher
DOI
10.5281/zenodo.21753813

Related papers

Quantum Oncology: The Applications of Quantum Computing in Cancer Research

Jiaran Li, Li Li, Ning Liu +3 more

Journal of Medical Systems•Jul 23, 2025•8 citations

Enhancing Breast Cancer Diagnosis with Quantum-Driven Generative Adversarial Models

V. Shankar Ganesh, Purushothaman Annadurai, A. Abdul Hayum +1 more

The framework proposed in this research work is a new approach for the breast cancer detection that will need the power of quantum computing, in which a Hamiltonian-based Quantum depending Generative type Adversarial Networks (QGAN) implementation will be done.For the diagnosis to be more accurate and efficient, the proposed system integrates the quantum mechanics with the machine learning algorithms.Through a quantum-inspired adversarial network, the system has been designed to accomplish function realization and optimization in the process of cancer detection.The Hamiltonian framework, as a strong foundation, is suitable for the generation of more realistic samples, allowing the system to articulate more agilely the subtle patterns and anomalies that are characteristic of medical imaging datasets.This method is one of the novel ways in which the model is able to neutralize some of the hindrances of classical machine learning models, for example, by doing so, the system can be faster and more precise in diagnosis by avoiding the problem of a longer conversion time and suboptimal feature extraction.The results show considerable diagnostic performance upgrades that improve treatment outcomes for thousands of women patients with the use of new technologies and new research techniques.

International Journal of Drug Delivery Technology•Sep 29, 2026•0 citations

Quantum computing for oncology

Siddhi Ramesh, Teague Tomesh, Samantha J. Riesenfeld +2 more

Nature Cancer•May 17, 2024•20 citations

Quantum Enhanced Prediction for Breast Cancer Electronic Health Records

Rajesh G, Madhumitha R, Sabarinath Arunagiri +1 more

Quantum computing technology allows for more efficient problem-solving and provides essentially distinct answers to computational challenges when compared to classical computations. Machine learning algorithms have come to the fore in medical research and offer promising avenues for increasing the accuracy of cancer diagnosis. Breast cancer represents the majority of cancer cases in women worldwide, making it a serious and widespread public health issue. Improving patient outcomes requires early identification of cancer. The proposed Quantum Enhanced Prediction (QEP) project delves into the predictive power of two distinct learning paradigms: Support Vector Machine and Quantum Support Vector Machine, using Wisconsin breast cancer dataset. The research underscores the complexity of algorithms in cancer prediction. A departure from the ZZ feature map in QSVM marked the beginning of an intentional shift from traditional design. However, the study looked at the integration of the Z element map and Pauli matrices, providing the foundation for improved accuracy and a better grasp of quantum mechanics in cancer prediction. This conceptual shift intends to investigate the possible influence of quantum computing on breast cancer prediction with more granularity.

IEEE International Conference on Signal Processing, Informatics, Communication and Energy Systems (SPICES)•Sep 20, 2024•2 citations

Quantum Computing: A New Frontier in Drug Discovery

Adhira Tippur

•Jan 1, 2025•0 citations

MQML: Multi-Omic Quantum Machine Learning Based Cancer Classification, Biomarker Identification in Human Lung Adenocarcinoma

Mandeep Kaur Saggi, Sabre Kais

Quantum machine learning (QML) presents novel opportunities for resolving, accelerating, and refining computational biology challenges. In biomedical research and personalized medicine, multi-omics integration offers a comprehensive understanding of complex biological systems, bridging the gap between basic research and clinical applications. Recent advancements in quantum computing could enhance multi-omics integration by leveraging unique quantum principles, potentially revealing intricate patterns in multi-omics datasets and offering new insights into the molecular landscape of lung cancer. This study focuses on the integration, feature selection, diagnostic classification, and biomarker identification of lung cancer types-LUAD primary tumor and solid tissue normal-using QML. Given the heterogeneity and high dimensionality of the data, we aim to assess the performance of QML in feature selection, reduction, encoding, and diagnostic classification in integrated multi-omics cancer datasets. We demonstrate the efficacy of Quantum Neural Networks (QNNs) for classifying multi-omics lung cancer data from The Cancer Genome Atlas, comparing our framework with 16 and 64 dimensions of feature using QML. Our results show that the Multi-omic Quantum Machine Learning (MQML) framework achieves superior classification performance with smaller training datasets, as determined by significant and non-significant p-values. This study provides empirical evidence for the potential application of unconventional computing approaches in biomed-ical sciences, particularly in oncology research, including cancer subtype diagnostic, survival, and stage classification. Key results include the identification of sixteen genes and thirty-two genes with the hybrid quantum-classical neural net-work model, with notable genes such as MIR632, CYP19A1, RP11-108K3.1, C14orf39, THUMPD1, ACSM3, GSC, MIR92a-2, DYRK1B, DNAJA1, IRX1, FMR1, POU2F2, MIR9-2, ZNF274, MIR196a-1, MIR3653, MIR33b, MIR301a, MIR182, MIR520a, PYGO2, EMX2OS, EMX2, RP11-550F7.1, RPS11, MIR20a, EIF4G2, IGLV1-47, RP11-180M15.7, SCYL3, AC107081.5, C2orf47, FST, MIR7-1, SLC22A18, CLDN5, and AC007879.7 identified as having significant and non-significant p-values asso-ciated with LUAD patient predictions.

IEEE International Conference on Quantum Computing and Engineering (QCE)•Sep 15, 2024•7 citations
The framework proposed in this research work is a new approach for the breast cancer detection that will need the power of quantum computing, in which a Hamiltonian-based Quantum depending Generative type Adversarial Networks (QGAN) implementation will be done.For the diagnosis to be more accurate and efficient, the proposed system integrates the quantum mechanics with the machine learning algorithms.Through a quantum-inspired adversarial network, the system has been designed to accomplish function realization and optimization in the process of cancer detection.The Hamiltonian framework, as a strong foundation, is suitable for the generation of more realistic samples, allowing the system to articulate more agilely the subtle patterns and anomalies that are characteristic of medical imaging datasets.This method is one of the novel ways in which the model is able to neutralize some of the hindrances of classical machine learning models, for example, by doing so, the system can be faster and more precise in diagnosis by avoiding the problem of a longer conversion time and suboptimal feature extraction.The results show considerable diagnostic performance upgrades that improve treatment outcomes for thousands of women patients with the use of new technologies and new research techniques.
Quantum computing technology allows for more efficient problem-solving and provides essentially distinct answers to computational challenges when compared to classical computations. Machine learning algorithms have come to the fore in medical research and offer promising avenues for increasing the accuracy of cancer diagnosis. Breast cancer represents the majority of cancer cases in women worldwide, making it a serious and widespread public health issue. Improving patient outcomes requires early identification of cancer. The proposed Quantum Enhanced Prediction (QEP) project delves into the predictive power of two distinct learning paradigms: Support Vector Machine and Quantum Support Vector Machine, using Wisconsin breast cancer dataset. The research underscores the complexity of algorithms in cancer prediction. A departure from the ZZ feature map in QSVM marked the beginning of an intentional shift from traditional design. However, the study looked at the integration of the Z element map and Pauli matrices, providing the foundation for improved accuracy and a better grasp of quantum mechanics in cancer prediction. This conceptual shift intends to investigate the possible influence of quantum computing on breast cancer prediction with more granularity.
Quantum machine learning (QML) presents novel opportunities for resolving, accelerating, and refining computational biology challenges. In biomedical research and personalized medicine, multi-omics integration offers a comprehensive understanding of complex biological systems, bridging the gap between basic research and clinical applications. Recent advancements in quantum computing could enhance multi-omics integration by leveraging unique quantum principles, potentially revealing intricate patterns in multi-omics datasets and offering new insights into the molecular landscape of lung cancer. This study focuses on the integration, feature selection, diagnostic classification, and biomarker identification of lung cancer types-LUAD primary tumor and solid tissue normal-using QML. Given the heterogeneity and high dimensionality of the data, we aim to assess the performance of QML in feature selection, reduction, encoding, and diagnostic classification in integrated multi-omics cancer datasets. We demonstrate the efficacy of Quantum Neural Networks (QNNs) for classifying multi-omics lung cancer data from The Cancer Genome Atlas, comparing our framework with 16 and 64 dimensions of feature using QML. Our results show that the Multi-omic Quantum Machine Learning (MQML) framework achieves superior classification performance with smaller training datasets, as determined by significant and non-significant p-values. This study provides empirical evidence for the potential application of unconventional computing approaches in biomed-ical sciences, particularly in oncology research, including cancer subtype diagnostic, survival, and stage classification. Key results include the identification of sixteen genes and thirty-two genes with the hybrid quantum-classical neural net-work model, with notable genes such as MIR632, CYP19A1, RP11-108K3.1, C14orf39, THUMPD1, ACSM3, GSC, MIR92a-2, DYRK1B, DNAJA1, IRX1, FMR1, POU2F2, MIR9-2, ZNF274, MIR196a-1, MIR3653, MIR33b, MIR301a, MIR182, MIR520a, PYGO2, EMX2OS, EMX2, RP11-550F7.1, RPS11, MIR20a, EIF4G2, IGLV1-47, RP11-180M15.7, SCYL3, AC107081.5, C2orf47, FST, MIR7-1, SLC22A18, CLDN5, and AC007879.7 identified as having significant and non-significant p-values asso-ciated with LUAD patient predictions.